Lexicon Pharmaceuticals LXRX Compensation and benefits
Compensation and benefits at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's compensation and benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's compensation and benefits?
- Lexicon Pharmaceuticals (LXRX) reported compensation and benefits of $3.08M in Q1 2026.
- How has Lexicon Pharmaceuticals's compensation and benefits changed year-over-year?
- Lexicon Pharmaceuticals's compensation and benefits increased by 1.2% year-over-year, from $3.04M to $3.08M.
- What is the long-term trend for Lexicon Pharmaceuticals's compensation and benefits?
- Over 4 years (2021 to 2025), Lexicon Pharmaceuticals's compensation and benefits has grown at a 4.3% compound annual growth rate (CAGR), from $10.58M to $12.52M.
- What does compensation and benefits mean?
- Total employee-related costs including salaries, wages, bonuses, commissions, stock-based compensation, health insurance, retirement contributions, and payroll taxes.